1. Home
  2. Labeler Index
  3. Avkare
  4. 42291-999
  5. Product Images: Zolmitriptan Od

Product Images Zolmitriptan Od

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. 1 - 998 06
  2. 1 - 999 03
  3. zolmitriptan structure - Structure
  4. fig 1 - figure 1
  5. fig 2 - figure 2
  6. fig 3 - figure 3
  7. fig 4 - figure 4

Product Label Images

The following 7 images provide visual information about the product associated with Zolmitriptan Od NDC 42291-999 by Avkare, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

1 - 998 06

1 - 998 06

This is a description for Zolmitriptan Orally Disintegrating Tablets, USP containing 25 mg of Zolmitriptan per tablet. The text provides information on dosage and usage instructions. It is recommended to store the medication at 20°C-25°C and protect it from light and moisture. Please refer to the prescribing information for more details.*

1 - 999 03

1 - 999 03

This is a description about Zolmitriptan Orally Disintegrating Tablets, USP containing 5 mg of the active ingredient. The text also includes handling instructions such as protecting from light and moisture and storing at controlled room temperature. The product is numbered with the NDC code 42291.990.03.*

zolmitriptan structure - Structure

zolmitriptan structure - Structure

fig 1 - figure 1

fig 1 - figure 1

fig 2 - figure 2

fig 2 - figure 2

This text appears to be a chart showing estimated probabilities of remedication over time from the initial dose. The probabilities are represented as percentages. The data may be used for evaluating the likelihood of needing additional doses of medication at different time points.*

fig 3 - figure 3

fig 3 - figure 3

This text provides information on the percentage distribution of Zolmitriptan Orally Disintegrating Tablets (2.5 mg) and Placebo over time intervals from 0.5 hour to 2 hours after the initial dose.*

fig 4 - figure 4

fig 4 - figure 4

This text appears to be a chart or table related to Zolmitriptan Orally Disintegrating Tablets, specifically focusing on the estimated probability of remedication or rescue over a period of 24 hours after the initial dose. It likely provides information on the dosage strength of 2.5 mg and how it correlates with the likelihood of needing additional medication within specific time intervals.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.